AR and neoplasm: Comprehensive genetic profiling, using institutional tumor next-generation sequencing panel Genetrails, of the pretreatment prostate biopsy showed genomic alterations in PIK3CA p.E542K, MUTYH p.G393D and androgen receptor (AR) amplification (11 copies).